Lamotrigine Tablet
Product Images NDC 71335-1110

7 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 71335-1110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 740 1)

FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)

Image (2d955155 686d 40cd 898e Df7d760247a5 789 2)
Lamotrigine oral tablets in various strengths and shapes are shown. The 25 mg white tablet is oval and imprinted with 'U U 111'. The 100 mg white tablet is round and imprinted with 'U U 112'. The 150 mg white tablet is triangular and imprinted with 'U U 113'. The 200 mg light blue tablet is triangular and imprinted with 'U U 114'.*
FDA Label Image

Image (2d955155 686d 40cd 898e Df7d760247a5 789 3)

FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)
Chemical structure of lamotrigine showing a chlorinated phenyl ring connected to a triazine ring substituted with amino groups.*
FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)
A survival curve chart showing failure probability percentage over weeks for Lamotrigine compared to placebo. The graph tracks failure probability up to around 100 weeks, with separate lines labeled for Lamotrigine and placebo, and censored data points indicated. The y-axis represents failure probability (%) and the x-axis represents time in weeks.*
FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)
This line graph displays failure probability (%) over time in weeks for Lamotrigine and Placebo groups. Two curves represent failure probabilities, with Lamotrigine showing a lower failure probability compared to Placebo throughout the study duration up to about 80 weeks. The graph includes censored data marks and labels the two groups.*
FDA Label Image

Label (Lbl713351110)

Label (Lbl713351110)
Label for Lamotrigine 150 mg Tablet by Bryant Ranch Prepack, packaged in Burbank, CA. The label references comparison to Lamictal 150 mg Tablet by Unichem Laboratories Limited. It indicates a quantity of 60 tablets, storage instructions at 20°-25°C (68°-77°F), and includes the NDC number 71335-1110-1 with a barcode and lot number 1523487.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.